Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
Homeless people, incarcerated individuals and people with mental health conditions achieved a high cure rate.
NAFLD is the leading indicator of mortality among Medicare beneficiaries with hepatocellular carcinoma.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
290 million people have viral hepatitis and don’t know it. Raise awareness with a virtual video relay.
The World Health Organization coordinates efforts to create flu and COVID-19 vaccines and to fight other global health issues.
Sofosbuvir and daclatasvir were linked to faster recovery and improved survival in studies in Iran.
Veteran bluesman Curtis Salgado was told his liver cancer would kill him in six months. That was 14 years ago.
People in their 20s and 30s now account for more than a third of newly reported chronic hep C.
New research shows that treating these viruses can reduce liver cancer risk.
Available vaccines offer protection against cervical, anal, oral, liver and stomach cancers.
Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.
All people ages 18 to 79 should be screened for hepatitis C virus at least once, regardless of risk factors.
Study results underline the importance of treating hepatitis C virus.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.